FDA Categorization Of Hybrid Medical Products Suggested By Science Board
This article was originally published in The Gray Sheet
Executive Summary
FDA should consider developing a system to categorize hybrid technologies that would help the agency evaluate which products might raise ethical concerns, FDA Science Board panel members recommended.
You may also be interested in...
Biotech Ethics Council Urged By Former FDAer/AdvaMed VP Benson
An advisory panel should be created to consider moral and ethical biotechnology issues faced by FDA and other health agencies, according to former FDA Acting Commissioner James Benson
Biotech Ethics Council Urged By Former FDAer/AdvaMed VP Benson
An advisory panel should be created to consider moral and ethical biotechnology issues faced by FDA and other health agencies, according to former FDA Acting Commissioner James Benson
CDRH Is Lead Center For Ten Combination Product Reviews In FY 2000
FDA's Center for Devices and Radiological Health was the lead center in ten reviews conducted during FY 2000 on combination products in which the area of jurisdiction was not clearcut.